Press Releases

Press Releases

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

Vaccine study confirms sensitivity of cholera test

Korean Pediatric Association, IVI, KSC exchange MOU

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

Henry Lau joins IVI as Goodwill Ambassador

Nature Communications study addresses MDR typhoid

THSTI, IVI held joint symposium on Nov. 22

‘The Euvichol story’ published in Vaccine

IVI accelerates development of MERS vaccine

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience



2018-04-20 02:18


The International Vaccine Institute (IVI), Seoul, Korea invites proposals from interested vendors for the supply of following goods and services.

1. Ref. No: IVI-PRNC/2018-0329-1
2. Time limit to submit the proposals: May 3 (Thu) 2018, 17:00, South Korea local time
3. Goods and services to supply: Redesign and update IVI website in English and host the site on the cloud. Please refer to the Attachment 2, “Technical Specification” for details.
4. Documents to submit:
1) Company profile
2) Proposal consisting of;
a. Price proposal: This should include a English website renewal fee, a monthly webhosting fee, warranty(1year), and maintenance plan
b. Technical proposal: This should include delivery time, company’s strength, personnel allocation plan, technical support plan and maintenance plan etc.
3) Financial and bank credit information of the vendor
4) Experience & reference details on similar jobs for the past 3years
5) URL links that the vendor has developed in recent 3years and is in operation
6) Copy of business registration
* For details, please refer to the “Attachment 1, Bid Guideline”
5. Bid briefing session: April 25 (Wed), 2018, 2:00pm, at IVI, Seoul Korea

IVI will review the proposals and select the bona fide vendor based on their ability, experience and financial terms. IVI reserves the right to cancel the bidding procedure if bids are not qualified. The short-listed bidders will be invited for presentation. A final successful bidder shall be notified to accept and sign the contract at the earliest.

Interested parties, please submit the requested documents to:

Ms. Claire (Heeyoung) Kang
International Vaccine Institute
SNU Research Park, 1 Gwanak-ro, Gwanak-gu,
Seoul, Korea 08826

For any questions, please contact Ms. Claire (Heeyoung) Kang at
Attachment : Bid_Guideline.docx